Beneficial ownership — 13D / 13G
87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | FMAC Future Money Acquisition Corp | 13G | 5.9% | Mar 31, 2026 | 6mo |
| Redmile Group, LLC | STOK Stoke Therapeutics, Inc. | 13G/A | 6.7% | Mar 31, 2026 | 6mo |
| TENOR CAPITAL MANAGEMENT Co., L.P. | PALO Paloma Acquisition Corp I | 13G/A | 4% | Mar 31, 2026 | 6mo |
| Orbis Investment Management Limited | NCMI National CineMedia, Inc. | 13G/A | 9.7% | Mar 31, 2026 | 6mo |
| Iroquois Capital Management, LLC | WRAP Wrap Technologies, Inc. | 13G/A | 4.99% | Mar 31, 2026 | 6mo |
| Avoro Capital Advisors LLC | SLNO Soleno Therapeutics Inc | 13G/A | 4.45% | Mar 31, 2026 | 6mo |
| Woodline Partners LP | XOMA XOMA Royalty Corp | 13G | 5.4% | Mar 31, 2026 | 6mo |
| Pentwater Capital Management LP | SGRY Surgery Partners, Inc. | 13G/A | 9.7% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | LPBB Launch Two Acquisition Corp. | 13G/A | 6.09% | Mar 31, 2026 | 6mo |
| Driehaus Capital Management LLC | ANDG Andersen Group Inc. | 13G/A | 4.43% | Mar 31, 2026 | 6mo |
| Palantir Technologies Inc. | SRFM Surf Air Mobility Inc. | 13G/A | 3.5% | Mar 31, 2026 | 6mo |
| AQR CAPITAL MANAGEMENT LLC | S SentinelOne, Inc. | 13G | 5.92% | Mar 31, 2026 | 6mo |
| Point72 Asset Management, L.P. | PALI Palisade Bio, Inc. | 13G/A | 0.2% | Mar 31, 2026 | 6mo |
| 5AM Partners VII, LLC | SRZN Surrozen, Inc. | 13G/A | 9.5% | Mar 31, 2026 | 6mo |
| CVI Investments, Inc. | SXTP 60 Degrees Pharmaceuticals, Inc. | 13G/A | 7% | Mar 31, 2026 | 6mo |
| North Reef Capital Management LP | ABCB Ameris Bancorp | 13G | 5.04% | Mar 31, 2026 | 6mo |
| Stonepine Capital Management, LLC | CNSP CNS Pharmaceuticals, Inc. | 13G/A | 9.9% | Mar 31, 2026 | 6mo |
| TCG Crossover GP II, LLC | VTGN Vistagen Therapeutics, Inc. | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| RTW INVESTMENTS, LP | IMTX Immatics N.V. | 13G/A | 9.6% | Mar 31, 2026 | 6mo |
| BROWN ADVISORY INC | EAGL Eagle Capital Select Equity ETF | 13G/A | 9.1% | Mar 31, 2026 | 6mo |
| GILDER GAGNON HOWE & CO LLC | BRCB Black Rock Coffee Bar, Inc. | 13G | 3.5% | Mar 31, 2026 | 6mo |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | DBCA D. Boral Acquisition I Corp. | 13G | 5.2% | Mar 31, 2026 | 6mo |
| 1607 Capital Partners, LLC | EFR Eaton Vance Senior Floating-Rate Trust | 13G | 5.37% | Mar 31, 2026 | 6mo |
| Balyasny Asset Management L.P. | NERV Minerva Neurosciences, Inc. | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| Longitude Capital Partners V, LLC | CTMX CytomX Therapeutics, Inc. | 13G/A | 7% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | GOVX GeoVax Labs, Inc. | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| AQR CAPITAL MANAGEMENT LLC | RPAY Repay Holdings Corp | 13G | 6.42% | Mar 31, 2026 | 6mo |
| GATE CITY CAPITAL MANAGEMENT, LLC | JAKK Jakks Pacific Inc | 13G/A | 8.5% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | INSP Inspire Medical Systems, Inc. | 13G/A | 8.8% | Mar 31, 2026 | 6mo |
| LMR Partners LLP | BZFD BuzzFeed, Inc. | 13G | 6.3% | Mar 31, 2026 | 6mo |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | FFIV F5, Inc. | 13G/A | 8.1% | Mar 31, 2026 | 6mo |
| VIKING GLOBAL INVESTORS LP | DNA Ginkgo Bioworks Holdings, Inc. | 13G/A | 7.1% | Mar 31, 2026 | 6mo |
| BIOTECHNOLOGY VALUE FUND L P | TENX Tenax Therapeutics, Inc. | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| TANG CAPITAL MANAGEMENT LLC | ALT Altimmune, Inc. | 13G/A | 0.3% | Mar 31, 2026 | 6mo |
| Point72 Asset Management, L.P. | ANGO Angiodynamics Inc | 13G/A | 7.7% | Mar 31, 2026 | 6mo |
| MACKENZIE FINANCIAL CORP | HCSG Healthcare Services Group Inc | 13G/A | 3.8% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | AWK American Water Works Company, Inc. | 13G | 5.8% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | LPX Louisiana-Pacific Corp | 13G | 6.2% | Mar 31, 2026 | 6mo |
| Nantahala Capital Management, LLC | FULC Fulcrum Therapeutics, Inc. | 13G/A | 4.58% | Mar 31, 2026 | 6mo |
| Bay Pond Partners, L.P. | MPB Mid Penn Bancorp Inc | 13G/A | 4.9% | Mar 31, 2026 | 6mo |
| LMR Partners LLP | ALF Centurion Acquisition Corp. | 13G/A | 4.8% | Mar 31, 2026 | 6mo |
| Foresite Capital Fund VI, L.P. | VSTM Verastem, Inc. | 13G/A | 3.6% | Mar 31, 2026 | 6mo |
| COHEN & STEERS, INC. | CCI Crown Castle Inc. | 13G/A | 9.35% | Mar 31, 2026 | 6mo |
| Berkshire Hathaway Inc | NYT New York Times Co | 13G | 9.4% | Mar 31, 2026 | 6mo |
| TD SECURITIES (USA) LLC | HDRN Hadron Energy, Inc. | 13G | 6.1% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | VLOS Velos Acquisition I Corp. | 13G/A | 13.52% | Mar 31, 2026 | 6mo |
| Woodline Partners LP | BJRI BJs RESTAURANTS INC | 13G/A | 4.6% | Mar 31, 2026 | 6mo |
| Global X Management CO LLC | NNE Nano Nuclear Energy Inc. | 13G | 5.64% | Mar 31, 2026 | 6mo |
| Commodore Capital LP | IKT Inhibikase Therapeutics, Inc. | 13G/A | 9.9% | Mar 31, 2026 | 6mo |
| KNIGHT THERAPEUTICS INC. | SXTP 60 Degrees Pharmaceuticals, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |